NX1NEXALIS THERAPEUTICS LTD

Issue of director share rights post shareholder approval

Date and time
Announcement type
Securities Administration

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case